David Schiff

29PUBLICATIONS
139CO-AUTHORS
Molecular targetsBiological adaptationPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Dec 29, 2025
Presenting clinical and radiographic features of diffuse glioma molecular subtypes in accordance with the 2021 CNS5 WHO classification.

Jasmin Jo, Mark Willy L Mondia, Josephine Arewa

|Aug 21, 2025
Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression.

Lalanthica V Yogendran, Abhinav Kareddy, Salma O Abbas

|Aug 19, 2025
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Patrick Y Wen, Michael Weller, Eudocia Q Lee

|Apr 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update.

Jaishri Blakeley, Nimish A Mohile, Hans Messersmith

Pageof 5

Frequent Collaborators

6 joint publications

Andrew Lassman

5 joint publications

Hans Messersmith

4 joint publications

P P Batchala

4 joint publications

Paul D Brown